A laser treatment for each glaucoma stage

As a world leader in lasers in Ophthalmology,
Lumibird Medical offer a comprehensive approach to Glaucoma LASER Therapy with treatment options at every stage of the disease paradigm.

Today, ophthalmologists can offer advanced glaucoma laser treatment options to patients, with greater safety and efficacy than ever before.

A laser treatment for each glaucoma stage

As a world leader in lasers in Ophthalmology,
Lumibird Medical offer a comprehensive approach to Glaucoma LASER Therapy with treatment options at every stage of the disease paradigm.

Today, ophthalmologists can offer advanced glaucoma laser treatment options to patients, with greater safety and efficacy than ever before.

Easily access to our clinical database

Find our latest clinical data regarding subliminal laser therapy

LATEST CLINICAL DATA

Access a range of clinical educational content, to all the clinical content available about for both macula and peripheral treatments, including: clinical articles, clinical videos, treatment guidelines…

Overcoming barriers to SLT as first line therapy for POAG & OH – Prof. Gus GAZZARD

12/10/2023
In this video, Prof. Gus GAZZARD , explains how to overcome barriers to SLT as first line therapy for POAG & OH. This video is from our symposium held at ESCRS 2023.

Selective Laser Trabeculoplasty as a First-line Treatment

17/05/2023
The glaucoma surgical landscape is evolving and changing dramatically as we move forward in the era of interventional glaucoma. The interventional glaucoma mindset represents a significant paradigm shift in patient care, taking the treatment burden out of the patient’s hands and placing more emphasis on earlier laser intervention.

SLT: Positive implications from the LiGHT study

07/03/2023
Glaucoma is a lifelong disease that requires continual monitoring and management. For many patients, glaucoma can be controlled medically—at least for a time—but the treatment is far from perfect. Complications, side effects, and compliance are common issues for those who rely on eye drops to control IOP. Other barriers to medical treatment include nonresponse to a medication, tachyphylaxis, and financial burden.

SLT as Frontline Therapy

19/12/2022
Selective laser trabeculoplasty (SLT) has come a long way in the last few years. The practice is gaining adherents as a first-line treatment for open-angle glaucoma for multiple reasons. And to give SLT a boost and provide an uber-coherent overview of the reasons in favor of SLT, Dr. Paul Singh spoke on its behalf at ESCRS 2022 in Milan.

Glaucoma treatment: Thermocyclo procedure

25/04/2022
Prof. Dr. Juan R. Sampaolesi, Head Glaucoma Center Buenos Aires, Argentina

Selective Laser Trabeculoplasty as a First-line Treatment

17/05/2023
The glaucoma surgical landscape is evolving and changing dramatically as we move forward in the era of interventional glaucoma. The interventional glaucoma mindset represents a significant paradigm shift in patient care, taking the treatment burden out of the patient’s hands and placing more emphasis on earlier laser intervention.

SLT: Positive implications from the LiGHT study

07/03/2023
Glaucoma is a lifelong disease that requires continual monitoring and management. For many patients, glaucoma can be controlled medically—at least for a time—but the treatment is far from perfect. Complications, side effects, and compliance are common issues for those who rely on eye drops to control IOP. Other barriers to medical treatment include nonresponse to a medication, tachyphylaxis, and financial burden.

Since 1993, Quantel Medical develops, manufactures and markets innovative medical laser and ultrasound solutions.

World leader in ophthalmology, its lasers and ultrasounds are designed to diagnose and treat the four main causes of blindness: cataracts, glaucoma, diabetic retinopathy and macular degeneration; and also dry eye disease.

Newsletter

"*" indicates required fields

Name*

The information collected through this form is recorded and transmitted to the relevant QUANTEL MEDICAL departments and enables us to send you any reply to a request via the contact form. The legal basis for the processing is consent. The data collected are kept for 3 years in digital format and are only transmitted to QUANTEL MEDICAL’s internal departments as well as to our distributors and subsidiaries. You have a right to access, rectify, contest, limit the processing of and erase data. For more information on the use of your data and your rights resulting from the amended French Data Protection Act and the GDPR, please consult our data protection policy or contact our Data Protection Officer at rgpd@quantelmedical.fr.

Country*
Consent
For more informations on how Quantel Medical uses your data, please see our Terms and conditions.
© 2024 Quantel Medical
Share this page by email
Share this page on facebook
Share this page on twitter
Share this page on linkedin